Target intelligence / Profile preview

Activin Receptor Type IIB (ActRIIB)

Target
ActRIIB
Molecular classification
Receptor, Serine/threonine kinase, TGF-beta superfamily receptor, Transmembrane protein
01

Overview

Activin receptor type IIB (ActRIIB), encoded by the ACVR2B gene, is a transmembrane serine/threonine kinase receptor that belongs to the transforming growth factor-beta (TGF-β) superfamily of receptors. It plays a central role in mediating signals from ligands such as activins and myostatin, which are involved in regulating cell growth, differentiation, and various physiological processes. Blocking ActRIIB or its interaction with ligands like myostatin has been explored as a therapeutic strategy for conditions involving muscle wasting.

Other names
ACVR2BActRIIBActivin receptor type-2B
02

Mechanism of action

Ligand binding induces formation of a heteromeric complex with type I receptors, leading to phosphorylation of SMAD proteins and regulation of gene transcription. Blocking ActRIIB or its interaction with ligands like myostatin inhibits signaling.

03

Biological functions

Signal transductionRegulation of skeletal muscle massFollicle-stimulating hormone biosynthesis/secretionApoptosisFibrosisInflammationNeurogenesisNeuronal differentiation/survivalHair follicle development/cyclingWound healingExtracellular matrix productionImmunosuppressionCarcinogenesis
04

Disease associations

Muscle wasting disordersMuscular dystrophySarcopeniaMetabolic diseasesCachexia syndromes

Beyond the preview

Go deeper on Activin Receptor Type IIB (ActRIIB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activin Receptor Type IIB (ActRIIB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call